Business Context and Reporting Period
This Form 8-K Current Report from AMERISAFE, INC. covers events occurring on June 6, 2025, specifically the Company's 2025 Annual Meeting of Shareholders held in DeRidder, Louisiana. The filing details the results of shareholder votes and corporate governance actions taken during the meeting.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. No financial statements are included in this document.
Material Changes and Shareholder Actions
Shareholders approved four key matters at the Annual Meeting. Of the 19,050,315 shares outstanding, 18,023,934 shares were represented at the meeting.
- Director Election: Teri G. Fontenot, Billy B. Greer, and Jared A. Morris were elected for terms expiring in 2028. Jared A. Morris received the highest number of withheld votes (2,078,938) compared to the other nominees.
- Executive Compensation: The advisory vote to approve the compensation of named executive officers was approved with 16,780,464 votes for and 726,212 votes against.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was ratified.
- Director Plan Amendment: Shareholders approved an amendment to the Non-Employee Director Restricted Stock Plan. This amendment increases the number of authorized shares available for issuance by 50,000 shares and raises the maximum annual target value of restricted stock grants to each non-employee director to $200,000.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The document focuses solely on the procedural outcomes of the Annual Meeting and the ratification of the Director Plan amendment.
Investor Verification Checklist
- Verify the full text of the amended Non-Employee Director Restricted Stock Plan (Exhibit 10.1) to understand the specific terms of the increased share authorization and grant limits.
- Review the 2025 Proxy Statement (filed April 30, 2025) for detailed context on the executive compensation package that was approved.
- Monitor future filings for the Company's next quarterly or annual report to obtain actual financial performance metrics, as none are present in this 8-K.
- Note the significant number of votes withheld for director nominee Jared A. Morris relative to other nominees, which may warrant further investigation into shareholder sentiment.